Head and Neck Cancer

Accelerated Disease Progression in Head, Neck Cancers Correlates With Cortisol Rhythm Disruption
Accelerated Disease Progression in Head, Neck Cancers Correlates With Cortisol Rhythm Disruption
Jordana JampelHead and Neck Cancer | December 12, 2024
The researchers hypothesized that the prognostic value of diurnal cortisol aberrations will hold in HNC.
Basement Membrane RNA Marker Identified for Head and Neck Squamous Cell Carcinoma
Basement Membrane RNA Marker Identified for Head and Neck Squamous Cell Carcinoma
Jordana JampelHead and Neck Cancer | November 11, 2024
Researchers aimed to find a marker to accurately predict the prognosis of HNSCC and to find novel immune targets.
Success in First Real-World Case of Relatlimab Combo for Treatment of Conjunctival Melanoma
Success in First Real-World Case of Relatlimab Combo for Treatment of Conjunctival Melanoma
Jordana JampelHead and Neck Cancer | November 7, 2024
The combo's use for conjunctival melanoma demonstrates the combinations high efficacy in treating complex disease.
Do Head and Neck Cancer Patients Experience Improved Quality of Life With Modern Radiotherapy Techniques?
Do Head and Neck Cancer Patients Experience Improved Quality of Life With Modern Radiotherapy Techniques?
Laura LitwinHead and Neck Cancer | October 23, 2024
The single-center, prospective study evaluated patient questionnaires to assess quality of life and physical function.
A Novel Prognostic Biomarker in Head and Neck Cancer
A Novel Prognostic Biomarker in Head and Neck Cancer
Rob DillardHead and Neck Cancer | October 23, 2024
BANF1 is a prognostic biomarker that can promote tumor expression in patients with HNSCC.
Oral Bacteria Associated With an Increased Risk of Head and Neck Cancer
Oral Bacteria Associated With an Increased Risk of Head and Neck Cancer
Rob DillardHead and Neck Cancer | September 27, 2024
Oral bacteria are a risk factor for head and neck squamous cell cancer.
Assessing a Novel Predictive Marker of Immune Checkpoint Response in Head and Neck Cancer
Assessing a Novel Predictive Marker of Immune Checkpoint Response in Head and Neck Cancer
Rob DillardHead and Neck Cancer | September 20, 2024
A novel predictive digital pathology biomarker demonstrates high predictive response in HNC.
Rice Research Initiative Awarded $18 Million on Tumor Analysis System for Breast, Head and Neck Cancers
Rice Research Initiative Awarded $18 Million on Tumor Analysis System for Breast, Head and Neck Cancers
Rob DillardHead and Neck Cancer | August 21, 2024
A multi-university research collaboration spearheaded by Rice University has been award $18 million for breast, HNC research.
Advertisement

Expert Interviews on Oncology

Advertisement
Advertisement
Advertisement
Latest News

ASPEN-06 Phase 2 Final Analysis Demonstrates Benefit of ALX148 Combination for Gastric Cancer

January 23, 2025

Changing Paradigms: Dr. Liu Discusses Implications of MARIPOSA OS Data

January 23, 2025

FDA Approves the First and Only Monotherapy for Treatment-Resistant Depression

January 23, 2025

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Editorial Policy

    Advertising

    Connect

    eNewsletters

    Contribute

    Contact Us

    Our Network

    MashupMD

    Blood Cancers Today

    Cancer Nursing Today

    GU Oncology Now

    Urban Health Today

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |